Triple-negative breast cancer (TNBC) represents one of the most aggressive breast cancer subtypes, characterized by the absence of estrogen receptors (ER), receptors (PR), and HER2 expression. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.